MORGAN STANLEY

Holdings History for IDEAYA Biosciences, Inc. - Common Stock, par value $0.0001 per share (IDYA)

Symbol: IDYA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0%	$58	1	0		$58.00 ^*	Q4 2025
31 Dec 2025	0%	-0%	$43,295,572	1,252,403	-327,950	-21%	$34.57	Q4 2025
30 Sep 2025	0%	+0%	$43,001,432	1,580,353	+126,976	+8.7%	$27.21	Q3 2025
30 Jun 2025	0%	-0%	$30,549,990	1,453,377	-233,211	-14%	$21.02	Q2 2025
31 Mar 2025	0%	+0%	$27,626,319	1,686,588	+131,508		$16.38	Q1 2025
31 Dec 2024	0%	+0%	$39,965,557	1,555,080	+1,194,444	+300%	$25.70	Q4 2024
30 Sep 2024		0%	$49	1	0		$49.00 ^*	Q3 2024
30 Sep 2024	0%	-0%	$11,424,949	360,636	-423,489		$31.68	Q3 2024
30 Jun 2024	0%	+0%	$27,530,681	784,125	+20,508		$35.11	Q2 2024
31 Mar 2024		0%	$68	1	0		$68.00 ^*	Q1 2024
31 Mar 2024	0%	-0%	$33,507,514	763,617	-469,654	-38%	$43.88	Q1 2024
31 Dec 2023	0%	+0%	$43,879,781	1,233,271	+1,000,495	+430%	$35.58	Q4 2023
30 Sep 2023	0%	-0%	$6,280,297	232,776	-119,790	-34%	$26.98	Q3 2023
30 Jun 2023	0%	+0%	$8,285,303	352,566	+261,814	+288%	$23.50	Q2 2023
31 Mar 2023	0%	+0%	$1,246,024	90,752	+32,635	+56%	$13.73	Q1 2023
31 Dec 2022	0%	+0%	$1,055,985	58,117	+9,099	+19%	$18.17	Q4 2022
30 Sep 2022	0%	-0%	$732,000	49,018	-36,928	-43%	$14.93	Q3 2022
30 Jun 2022	0%	-0%	$1,185,000	85,946	-34,884	-29%	$13.79	Q2 2022
30 Jun 2022		0%	$1,000	100	0		$10.00 ^*	Q2 2022
31 Mar 2022	0%	+0%	$1,352,000	120,830	+81,637	+208%	$11.19	Q1 2022
31 Dec 2021	0%	+0%	$926,000	39,193	+11,810	+43%	$23.63	Q4 2021
30 Sep 2021	0%	+0%	$698,000	27,383	+15,825	+137%	$25.49	Q3 2021
30 Jun 2021	0%	+0%	$243,000	11,558	+11,327	+4903%	$21.02	Q2 2021
31 Mar 2021	0%	-0%	$6,000	231	-11,719	-98%	$25.97	Q1 2021
31 Dec 2020	0%	+0%	$167,000	11,950	+7,341	+159%	$13.97	Q4 2020
30 Sep 2020	0%	-0%	$58,000	4,609	-2,107	-31%	$12.58	Q3 2020
30 Jun 2020	0%	+0%	$96,000	6,716	+6,192	+1182%	$14.29	Q2 2020
31 Mar 2020	0%	0%	$2,000	524	-376	-42%	$3.82	Q1 2020
31 Dec 2019	0%	+0%	$7,000	900	+900	NEW	$7.78	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.